Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Detrusor Hyperreflexia of Bladder”

42 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 42 results

Not applicableStudy completedNCT01226706
What this trial is testing

Efficacy of Botulinum Toxin Type A for the Treatment of Non-neurogenic Urinary Urge Incontinence

Who this might be right for
Urinary Urge Incontinence
Saskatchewan Health Authority - Regina Area 21
Early research (Phase 1)Study completedNCT01539707
What this trial is testing

Single Dose Study to Measure Blood Levels and Safety of a Drug for Children With Overactive Bladder

Who this might be right for
Overactive BladderNeurogenic Detrusor Overactivity
Astellas Pharma Inc 14
Early research (Phase 1)Study completedNCT02526979
What this trial is testing

Evaluate the Pharmacokinetics, Safety and Tolerability of Mirabegron Oral Suspension in Pediatric Subjects From 3 to Less Than 12 Years of Age With Neurogenic Detrusor Overactivity (NDO) or Overactive Bladder (OAB)

Who this might be right for
Overactive BladderNeurogenic Detrusor Overactivity
Astellas Pharma Europe B.V. 9
Post-approval studies (Phase 4)Study completedNCT00224016
What this trial is testing

Safety and Efficacy Study of Transdermal Oxybutynin to Treat Overactive Bladder With a Neurological Condition

Who this might be right for
Detrusor Hyperreflexia
Watson Pharmaceuticals 57
Large-scale testing (Phase 3)Study completedNCT01091727
What this trial is testing

Intravesical Injection of Botulinum Toxin A Versus Saline for Neurogenic Detrusor Overactivity

Who this might be right for
Neurogenic Detrusor Overactivity
Sunnybrook Health Sciences Centre 57
Not applicableStudy completedNCT03388086
What this trial is testing

Efficacy of Two Onabotulinum Toxin Doses

Who this might be right for
Neurogenic BladderOveractive Detrusor
Swiss Paraplegic Research, Nottwil 56
Post-approval studies (Phase 4)Study completedNCT00629642
What this trial is testing

Clinical Study of Solifenacin Succinate in Patients With Bladder Symptoms Due to Spinal Cord Injury or Multiple Sclerosis

Who this might be right for
Multiple SclerosisNeurogenic BladderSpinal Cord Diseases
Astellas Pharma Inc 249
Post-approval studies (Phase 4)Study completedNCT02601287
What this trial is testing

A Safety and Efficacy Study of Botulinum Toxin Type A (BOTOX®) to Treat Urinary Incontinence Due to Neurogenic Detrusor Overactivity or Overactive Bladder in Korean Patients

Who this might be right for
Urinary IncontinenceOveractive Bladder
Allergan 168
Not applicableStudy completedNCT06059066
What this trial is testing

Optimization of OnabotulinumtoxinA (BTX-A) Injection for the Treatment of Neurogenic Lower Urinary Tract Dysfunction

Who this might be right for
Neurogenic BladderLower Urinary Tract SymptomsOveractive Bladder+2 more
The Methodist Hospital Research Institute 78
Testing effectiveness (Phase 2)Study completedNCT00857896
What this trial is testing

Study Of Fesoterodine In Pediatric Overactive Bladder Patients Aged 8-17 Years

Who this might be right for
Overactive BladderNeurogenic Detrusor Overactivity
Pfizer 21
Not applicableStudy completedNCT02010788
What this trial is testing

Evaluation of Safety and Efficacy of Botulinum Toxin Type A (BOTOX®) to Treat Urinary Incontinence Due to Neurogenic Detrusor Overactivity or Overactive Bladder in Korea

Who this might be right for
Urinary IncontinenceUrinary Bladder, Overactive
Allergan 523
Testing effectiveness (Phase 2)WithdrawnNCT00262496
What this trial is testing

Botulinum-A Toxin Injection for Detrusor Hyperreflexia in Spinal Cord Injury: A Non-Surgical Approach.

Who this might be right for
Overactive BladderUrinary Incontinence
US Department of Veterans Affairs
Not applicableStudy completedNCT01297660
What this trial is testing

Neuro-urological Outcome After Spinal Cord Injury

Who this might be right for
Urinary Bladder Neurogenic Dysfunction
Balgrist University Hospital 55
Not applicableWithdrawnNCT01043848
What this trial is testing

Treatment of Neurogenic Detrusor Overactivity: Early Versus Late Pudendal Nerve Stimulation in Spinal Cord Injury (SCI) Patients

Who this might be right for
Neurogenic Detrusor OveractivitySpinal Cord Injury
Ulrich Mehnert
Large-scale testing (Phase 3)Ended earlyNCT00667095
What this trial is testing

Over Active Bladder Instillation Study - Botox

Who this might be right for
Overactive BladderUrinary Urge IncontinenceUrinary Incontinence+2 more
Mayo Clinic 25
Testing effectiveness (Phase 2)UnknownNCT03187795
What this trial is testing

Mirabegron and Oxybutynin Safety and Efficacy Trial in Spinal Cord Injury

Who this might be right for
Spinal Cord InjuriesUrinary Bladder, Neurogenic
Kessler Foundation 62
Early research (Phase 1)Study completedNCT02211846
What this trial is testing

Evaluate the Pharmacokinetics, Safety and Tolerability of Mirabegron OCAS (Oral Controlled Absorption System) in Pediatric Subjects With Neurogenic Detrusor Overactivity or Overactive Bladder

Who this might be right for
Neurogenic Detrusor OveractivityOveractive BladderPharmacokinetics of Mirabegron
Astellas Pharma Inc 34
Large-scale testing (Phase 3)Study completedNCT01530620
What this trial is testing

Efficacy and Tolerability of Propiverine Hydrochloride in Patients With Neurogenic Detrusor Overactivity

Who this might be right for
Neurogenic Urinary Bladder DisorderUrinary Bladder, NeurogenicBladder Disorder, Neurogenic+6 more
APOGEPHA Arzneimittel GmbH 66
Large-scale testing (Phase 3)Study completedNCT02849418
What this trial is testing

Efficacy and Safety Study of GSK1358820 in Japanese Patients With Urinary Incontinence Due to Neurogenic Detrusor Overactivity

Who this might be right for
Urinary Bladder, Overactive
GlaxoSmithKline 21
Large-scale testing (Phase 3)Ended earlyNCT02660138
What this trial is testing

Dysport® Treatment of Urinary Incontinence in Adults Subjects With Neurogenic Detrusor Overactivity (NDO) Due to Spinal Cord Injury or Multiple Sclerosis - Study 1

Who this might be right for
Urinary IncontinenceOveractive Bladder
Ipsen 227
Load More Results